DC Funds, LP
- SEC CIK
- 0001869028
- Latest filing
- Aug 14, 2026
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 3
- 0 vs. Q2 2022
- Portfolio value
- $6.63M
- −$614.0K (−8.5%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| HOWLWerewolf Therapeutics, Inc. | COM | 589,102 | $2.66M | 40.1% | 00.0% | Unchanged | History |
| BRNSBarinthus Biotherapeutics plc. | ADS | 642,204 | $2.06M | 31.0% | 00.0% | Unchanged | History |
| TCRXTScan Therapeutics, Inc. | COM | 630,000 | $1.92M | 29.0% | 00.0% | Unchanged | History |